MoneyWorks4Me

Ajanta Pharma informs about board meeting

15 Oct 2026 Evaluate
Ajanta Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 to consider and approve Unaudited consolidated and standalone financial results of the Company for the second quarter and half year ended 30th September 2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..